Stephanie Faure - Publications

Immune checkpoint inhibitors after liver transplantation: The role of immunosuppressive management.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: August 07, 2025

Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: June 16, 2025

Disparities in transplant access and outcomes after first cirrhosis decompensation in alcohol-related liver disease.

Journal: JHEP reports : innovation in hepatology

Published: April 04, 2025

Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial.

Journal: The lancet. Gastroenterology & hepatology

Published: March 28, 2025

Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A French National Cohort Study Including 571 Patients.

Journal: The American journal of gastroenterology

Published: February 28, 2025

Ursodeoxycholic Acid Alone Is Effective and Safe to Treat Cholestatic Checkpoint Inhibitor-Induced Liver Injury.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: December 30, 2024

VCTE and Liver Transplantation: Is There Still a Role for Liver Biopsy?

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: December 28, 2024

Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or Gougerot-Sjögren's disease: Prepcov multicentre trial.

Journal: Lupus science & medicine

Published: October 31, 2024

Acceptability of non-invasive liver fibrosis screening in psychiatric settings.

Journal: L'Encephale

Published: July 20, 2024

Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury, as assessed for causality using the updated RUCAM.

Journal: Alimentary pharmacology & therapeutics

Published: June 18, 2024

Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse.

Journal: JHEP reports : innovation in hepatology

Published: April 14, 2023

Bariatric surgery and liver transplantation, here we are now: A French nationwide retrospective study.

Journal: Clinics and research in hepatology and gastroenterology

Published: March 07, 2023